摘要
随着精准医学概念的提出,肿瘤的精准化靶向治疗也进入了新的阶段。肺癌分子生物学研究的不断进展促进了众多分子靶点的发现。新型靶向药物的问世及大型临床研究数据的更新为肺癌的精准化治疗带来了更多的选择和希望。本文就近几年来肺癌的靶向治疗与精准医学的发展与趋势进行综述。
With the promotion of precision medicine, tumor targeted therapy has entered into a new stage. Developments in molecular biotechnology have contributed to the discovery of numerous novel molecular targets. The advent of new targeted drugs and continuous updating data from large clinical research have provided more options for the precise treatments of lung cancer. This article aims to review the latest progress about targeted therapy and precision medicine in lung cancer.
作者
周彩存
刘桑田
ZHOU Cai-cun;LIU Sang-tian(Department of Medical Oncology, Shanghai Pulmonary Hospital, Shanghai 200433, Chin)
出处
《医学研究生学报》
CAS
北大核心
2017年第11期1132-1139,共8页
Journal of Medical Postgraduates
关键词
非小细胞肺癌
靶向治疗
精准医学
表皮生长因子受体
间变性淋巴瘤激酶
Non-small Cell Lung Cancer
Targeted Therapy
Precision Medicine
Epidermal growth factor receptor
The anaplastic lymphoma kinase